CMCao Ma

Cao Ma

*This is an algorithmically generated author record based on publicly available information.

Cao Ma has a total of 14 co-authors. Here are the top co-authors by number of shared publications:

  • Zhiwen Zhang

    Fuwai Central China Cardiovascular Hospital, Zhengzhou, China

    2 shared publications
  • Donghui Chen

    Zhengzhou University People's Hospital, Central China Fuwai Hospital of Zhengzhou University, Fuwai Central China Cardiovascular Hospital Zhengzhou China

    1 shared publication
  • Haosen Yu

    Zhengzhou University People's Hospital, Central China Fuwai Hospital of Zhengzhou University, Fuwai Central China Cardiovascular Hospital Zhengzhou China

    1 shared publication
  • Mingxing Lv

    Zhengzhou University People's Hospital, Central China Fuwai Hospital of Zhengzhou University, Fuwai Central China Cardiovascular Hospital Zhengzhou China

    1 shared publication
  • Muwei Li

    Fuwai Central China Cardiovascular Hospital, Zhengzhou, China

    1 shared publication
  • Muwei Li

    Department of Cardiology, Fuwai Central China Cardiovascular Hospital, Central China Fuwai Hospital of Zhengzhou University

    1 shared publication

Latest Publications

  • Open Access

    Refining Free Light Chain Ratio in Systemic Amyloidosis

    by Zhiwen Zhang, Quan Guo, Yang Gao, Muwei Li, Cao Ma

  • Open Access

    Impact of Insomnia on Myocardial Infarction Risk and Coronary Plaque Vulnerability: Insights From Mendelian Randomization and OCT Imaging

    by Yang Gao, Qingbo Shi, Zhuocheng Shi, Zhiwen Zhang, Haosen Yu, Mingxing Lv, Tong Zhang, Donghui Chen, Yu Shuo Gu, Quan Guo, et al.

    Background: Insomnia is a prevalent sleep disorder increasingly recognized as a risk factor for cardiovascular diseases (CVDs). However, its causal relationship with myocardial infarction (MI) and its impact on coronary plaque vulnerability remain poorly understood. Methods: We performed Mendelian randomization (MR) analysis using genome‐wide association study (GWAS) summary data for insomnia ( n = 462,341) and MI ( n = 484,598) in populations of European descent. Additionally, 340 patients with coronary artery disease (CAD) underwent coronary angiography and optical coherence tomography (OCT) imaging. Insomnia was assessed by the Insomnia Severity Index (ISI), and OCT was used to evaluate plaque features including thin‐cap fibroatheroma (TCFA), fibrous cap thickness, lipid arc, macrophage infiltration, and plaque rupture. Results: MR analysis showed a potential causal effect of genetically predicted insomnia on MI risk (OR = 1.015; 95% CI: 1.004–1.027; p = 0.007), with no evidence of pleiotropy or heterogeneity. Clinically patients with insomnia (ISI ≥ 8) had higher rates of hypertension (54.3% vs. 39.6%) and MI (32.4% vs. 21.7%), elevated CRP levels, and exhibited greater plaque vulnerability on OCT, including increased incidence of TCFA (29.5% vs. 17.0%), thinner fibrous caps, larger lipid arcs, and more frequent macrophage infiltration and plaque rupture. Logistic regression identified both insomnia (OR = 1.806; p = 0.037) and CRP (OR = 1.384; p = 0.034) as independent predictors of TCFA. Conclusions: This study provides genetic and clinical evidence that insomnia contributes to MI risk and coronary plaque vulnerability, underscoring the importance of addressing sleep disturbances in CAD management.